These findings reinforce the central role of ADAMTS-13:AC in the pathogenesis of PVT in patients with LC and suggest that ADAMTS-13 activity exclusively serves as a diagnostic and prognostic marker in patients with LC. Here, ADAMTS13 is linked to laryngotracheoesophageal cleft.